[1] 谷铣之,殷蔚伯,余子豪,等. 肿瘤放射治疗学[M]. 北京:中国协和医科大学联合出版社,2007:1122－1131.
[2] Salcman M,Scholtz H,Kaplan RS,et al. Long-term survival in patients with malignant astrocytoma[J]. Neurosurgery,1994,34(2):213－219.
[3] Hegi ME,Diserens AC,Gorlia T,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma[J]. N Engl J Med,2005,352(10):997－1003.
[4] Asthagiri AR,Pouratian N,Sherman J,et al. Advances in brain tumor surgery[J]. Neurol Clin,2007,25(4):975－1003.
[5] 印海林,吴伟莉,金风,等. 调强放射治疗联合同步及辅助替莫唑胺化疗治疗脑胶质瘤术后残余病灶的临床研究[J]. 肿瘤,2011,31(5):428－431.
[6] 王若峥,王多明. 调强放疗与替莫唑胺联合治疗颅内恶性胶质瘤 16 例临床分析[J]. 广西医科大学学报,2008,25(5):796－797.
[7] 张海霞,张春霞. 口服抗肿瘤新药替莫唑胺[J]. 国外医学:肿瘤学分册,1999,26(5):292－293.
[8] 李方明,聂青,徐世侠,等. 高度恶性脑胶质瘤放疗联合替莫唑胺(国产) 化疗临床研究[J]. 海军总医院学报,2009,22(1):6－9.
[9] Sun YH,Zhang YZ,Wang HC,et al. Relationship between the expression of O6-methylgunine-DNA methyltransferase in glioma and the survival time of patients[J]. Ai Zheng,2004,23(9):1052－1055.
[10] 杨群英,牟永告,李刚,等. MGMT 表达指导恶性胶质瘤的替莫唑胺化疗:附 40 例报告[J]. 中华神经外科杂志,2011,27(2):112－115.